Description
For laboratory research use only. Not for human consumption.
Wolverine Stack 10mg (BPC-157 5mg + TB500 5mg) is listed by TruGen for laboratory research use only. The quantity below is the catalog declaration, not a batch-certified measurement. Supplier specifications and a matching certificate of analysis are required to finalize the material details.
Product details
| Catalog name | Wolverine Stack 10mg (BPC-157 5mg + TB500 5mg) |
|---|---|
| SKU | TG-PREVIEW-046 |
| Material category | Research blend — component confirmation required |
| Listed quantity | 5 mg BPC-157 + 5 mg TB500 (10 mg combined catalog declaration) |
| Physical form / appearance | Pending supplier confirmation; lyophilization is not assumed. |
| Identity and chemical form | Multiple components; there is no single molecular formula or molecular weight for this mixture. |
| Purity / analytical method | Pending matching COA; no numerical purity claim assigned. |
| Content / potency | Pending lot-specific result and measurement basis. |
| Lot number / COA | To be linked when matching documents are supplied. |
Overview
This Wolverine Stack listing combines the catalog-designated components BPC-157 and TB500. The name describes a proposed research mixture; it does not establish synergy, tissue repair or a combined biological effect.
Chemical and physical properties
| Molecular formula / molecular weight | Not applicable as a single value to a multi-component blend. |
|---|---|
| Counterion / excipients | Pending full supplier specification. |
| Solubility / working pH | No universal solvent or pH is specified; use a method supported for the confirmed material. |
| Storage / transport | Pending supplier-supported conditions for the supplied formulation. |
| Prepared-solution stability | Not yet established; no fixed use period assigned. |
Research context
Component identification
Confirm the BPC-157 structure and the exact material designated TB500. The latter name requires a complete sequence before assigning a scientific profile.
Mixture evaluation
Any study of the blend should distinguish the full mixture from its separate components. Component-only literature cannot establish the stability, interaction profile or activity of the finished blend.
No compound-specific reference is assigned while identity or mixture validation remains unresolved. Supplier documentation is needed before selecting relevant scientific literature.
Published experimental observations do not establish a benefit in people, a clinical indication, or the performance of the supplied material. Suitability for a particular assay depends on verified identity, material quality and the researcher’s validated method. A catalog quantity is not a dose or a preparation instruction.
Quality and batch documentation
A matching COA should be reviewed alongside the supplier specification. The following information is requested, not represented as testing already performed:
- Lot identifier and a report that names the matching compound or formulation.
- Identity result from an appropriate method, with the tested structure or component identities stated.
- Purity result, analytical method and test date, distinguished from actual content or biological potency.
- Content basis, counterions, water and formulation ingredients where relevant to interpreting the result.
- Any additional tests needed for the intended assay, such as residual solvents, endotoxin or microbiological measurements, with the actual results reported.
Analytical purity does not by itself establish quantity, biological potency or sterility. No HPLC-verified, sterile or numerical-purity claim is made without the corresponding evidence.
Storage and shipping
Storage conditions must be based on the supplied chemical form, formulation and supporting stability information. No freezer temperature, room-temperature shipping tolerance or post-preparation shelf life is claimed here. Review documented shipping conditions and the condition of the container on receipt; resolve discrepancies before use. For a mixture, documentation must address the combined formulation rather than borrowing the storage or solubility of one component.
Laboratory preparation and handling
Plan preparation within the laboratory’s validated method and documented handling requirements.
- Confirm the product identity, lot, supplier specification and applicable laboratory risk assessment before opening the container.
- Select a solvent, concentration and preparation procedure supported by the confirmed material and the laboratory method. This page does not prescribe a reconstitution recipe.
- Use appropriate laboratory equipment, protective measures and controls. Record preparation date, lot, solvent and concentration in the laboratory record.
- Label prepared material clearly and follow documented stability limits. Do not infer a working-solution lifetime from an unopened-container storage recommendation.
- Dispose of unused material and contaminated supplies under the laboratory’s established chemical-waste procedures.
Research-use restrictions
For laboratory research use only. Not for human consumption or administration. Not intended for veterinary treatment, diagnosis, therapy, dietary supplementation, cosmetic application or recreational use. Handling is restricted to appropriately trained personnel in a suitable laboratory. Any work involving animals must follow the applicable institutional protocol and approvals; this description provides no administration instructions.
Product inquiries
For product documentation, lot questions or research-order inquiries, contact endobuyer@gmail.com and include the product name, SKU and lot number when available. Request the matching COA and handling specification before relying on a batch-specific claim.
